SARITHA CHANDINI THUMMA MD NPI 1952445223

NPI Details

Saritha Chandini Thumma, MD is a hematology and oncology internal medicine in Spokane, WA with 28 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Saritha Chandini Thumma, MD NPI is 1952445223. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

601 S SHERMAN ST
SPOKANE, WA
ZIP 99202-311
Phone: (509) 228-1000
Fax: (509) 252-9300

The NPI 1952445223 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Unclassified drugs (HCPCS:J3490)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Ct scan of chest with contrast (HCPCS:71260)
• Drawing of blood for a medical problem (HCPCS:99195)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Injection of drug or substance into vein (HCPCS:96374)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Urinalysis, manual test (HCPCS:81002)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Ct scan of chest without contrast (HCPCS:71250)

The enumeration date for this NPI number is 2/19/2007 and was last updated on 1/8/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.